BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• BioMidwest

  Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3

  Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced a research collaboration with the National Cancer Center Hospital East in Japan to study the prognostic and predictive value of molecular residual disease testing.

  February 27, 2024

   · 

  4 min read
• Business

  InBrain Pharma Announces the Appointment of Dr Véronique Foutel as CEO

  InBrain Pharma, a biotech specialized in brain infusion of drugs for neurological disorder management, announced the appointment of Dr. Véronique Foutel as CEO to drive the next company’s development steps.

  February 27, 2024

   · 

  4 min read
• Business

  MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor

  MAIA Biotechnology, Inc., a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, announced the appointment of immuno-oncology leader Remus Vezan, M.D., Ph.D., to its Scientific Advisory Board.

  February 27, 2024

   · 

  6 min read
• Business

  Corey Cutler, MD, MPH Named 2024-2025 President of ASTCT

  The American Society for Transplantation and Cellular Therapy® announced Corey Cutler, MD, MPH as the President of the Society in 2024-2025.

  February 27, 2024

   · 

  2 min read
• Business

  Atrion Corporation Declares Quarterly Cash Dividend - February 27, 2024

  Atrion Corporation announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock.

  February 27, 2024

   · 

  1 min read
• Business

  Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

  Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI) today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance.

  February 27, 2024

   · 

  19 min read
• Biotech Bay

  Terns Pharmaceuticals to Participate in Upcoming March 2024 Investor Conferences

  Terns Pharmaceuticals, Inc. announced that members of senior management will be participating in the following upcoming investor conferences in March.

  February 27, 2024

   · 

  1 min read
• Business

  PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

  PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended December 31, 2023.

  February 27, 2024

   · 

  13 min read
• Business

  Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

  Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2023.

  February 27, 2024

   · 

  15 min read
• Business

  OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

  OPKO Health, Inc. reports business highlights and financial results for the three and 12 months ended December 31, 2023.

  February 27, 2024

   · 

  11 min read